{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:07:15Z","timestamp":1790168835995,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["UG1EY020522"],"award-info":[{"award-number":["UG1EY020522"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41433-026-04815-4","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:26Z","timestamp":1786980506000},"page":"2143-2144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of blepharitis in adults: persistent evidence gaps despite widespread use"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3552-6195","authenticated-orcid":false,"given":"Kaleb S.","family":"Abbott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hsun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9350-5478","authenticated-orcid":false,"given":"Irene C.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"4815_CR1","doi-asserted-by":"publisher","first-page":"P50","DOI":"10.1016\/j.ophtha.2023.12.036","volume":"131","author":"A Lin","year":"2024","unstructured":"Lin A, Ahmad S, Amescua G, Cheung AY, Choi DS, Jhanji V, et al. Blepharitis preferred practice pattern\u00ae. Ophthalmology. 2024;131:P50\u2013P86.","journal-title":"Ophthalmology"},{"key":"4815_CR2","doi-asserted-by":"publisher","first-page":"e2022113","DOI":"10.5826\/dpc.1203a113","volume":"12","author":"S G\u00fcder","year":"2022","unstructured":"G\u00fcder S, \u00c7ulfa \u015e. Facial Dermatoses in Patients With Blepharitis: a Cross-sectional Prospective Analysis. Dermatol Pr Concept. 2022;12:e2022113.","journal-title":"Dermatol Pr Concept"},{"key":"4815_CR3","first-page":"300","volume":"78","author":"MR Dias","year":"2019","unstructured":"Dias MR, Guaresch BLV, Borges CR, Biazim DF, Casagrande D, Luz RA. Blepharitis: epidemiology, etiology, clinical presentations, treatment and evolution of our patients. Rev Brasileira de Oftalmologia. 2019;78:300\u20133.","journal-title":"Rev Brasileira de Oftalmologia"},{"key":"4815_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1542-0124(12)70620-1","volume":"7","author":"MA Lemp","year":"2009","unstructured":"Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf. 2009;7:S1\u2013S14.","journal-title":"Ocul Surf"},{"key":"4815_CR5","first-page":"774","volume":"44","author":"G Venturino","year":"2003","unstructured":"Venturino G, Bricola G, Bagnis A, Traverso C. Chronic blepharitis: treatment patterns and prevalence. Investigative Ophthalmol Vis Sci. 2003;44:774\u2013774.","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"4815_CR6","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s40265-023-01947-9","volume":"83","author":"YY Syed","year":"2023","unstructured":"Syed YY. Lotilaner ophthalmic solution 0.25%: first approval. Drugs. 2023;83:1537\u201341.","journal-title":"Drugs"},{"key":"4815_CR7","first-page":"CD013550","volume":"2016","author":"KW Kam","year":"2026","unstructured":"Kam KW, Mehraban Far P, Yim TW, Chen LJ, Mak CY, Young AL. Topical immunosuppressants for blepharitis in adults. Cochrane Database Syst Rev. 2026;2016:CD013550.","journal-title":"Cochrane Database Syst Rev"},{"key":"4815_CR8","unstructured":"Yan X-M, Sun X-G, Xie H-P, Hong J, Wang Z-C. Effects of tobramycin dexamethasone eye ointment for blepharitis: multi-center clinical trial; 2013."},{"key":"4815_CR9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.2147\/OPTH.S110739","volume":"10","author":"K Hosseini","year":"2016","unstructured":"Hosseini K, Lindstrom RL, Foulks G, Nichols KK. A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin\u20130.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment of subjects with blepharitis. Clin Ophthalmol. 2016;10:1495\u2013503.","journal-title":"Clin Ophthalmol"},{"key":"4815_CR10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2147\/OPTH.S109663","volume":"10","author":"CA Blackie","year":"2016","unstructured":"Blackie CA, Coleman CA, Holland EJ. The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye. Clin Ophthalmol. 2016;10:1385\u201396.","journal-title":"Clin Ophthalmol"},{"key":"4815_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/ceo.12033","volume":"41","author":"JV Greiner","year":"2013","unstructured":"Greiner JV. Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment. Clin Exp Ophthalmol. 2013;41:524\u201330.","journal-title":"Clin Exp Ophthalmol"},{"key":"4815_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clae.2017.10.012","volume":"41","author":"O Murphy","year":"2018","unstructured":"Murphy O, O\u2019Dwyer V, Lloyd-McKernan A. The efficacy of tea tree face wash, 1, 2-Octanediol and microblepharoexfoliation in treating Demodex folliculorum blepharitis. Cont Lens Anterior Eye. 2018;41:77\u201382.","journal-title":"Cont Lens Anterior Eye"},{"key":"4815_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/02713683.2018.1536217","volume":"44","author":"X Zhang","year":"2019","unstructured":"Zhang X, Song N, Gong L. Therapeutic Effect of Intense Pulsed Light on Ocular Demodicosis. Curr Eye Res. 2019;44:250\u20136.","journal-title":"Curr Eye Res"},{"key":"4815_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3143469","volume":"2019","author":"F Ruan","year":"2019","unstructured":"Ruan F, Zang Y, Sella R, Lu H, Li S, Yang K, et al. Intense Pulsed Light Therapy with Optimal Pulse Technology as an Adjunct Therapy for Moderate to Severe Blepharitis-Associated Keratoconjunctivitis. J Ophthalmol. 2019;2019:3143469.","journal-title":"J Ophthalmol"},{"key":"4815_CR15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.clae.2018.06.002","volume":"41","author":"KY Seo","year":"2018","unstructured":"Seo KY, Kang SM, Ha DY, Chin HS, Jung JW. Long-term effects of intense pulsed light treatment on the ocular surface in patients with rosacea-associated meibomian gland dysfunction. Cont Lens Anterior Eye. 2018;41:430\u20135.","journal-title":"Cont Lens Anterior Eye"},{"key":"4815_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.768849","volume":"8","author":"C Wang","year":"2021","unstructured":"Wang C, Dou X, Li J, Wu J, Cheng Y, An N. Composition and Diversity of the Ocular Surface Microbiota in Patients With Blepharitis in Northwestern China. Front Med (Lausanne). 2021;8:768849.","journal-title":"Front Med (Lausanne)"},{"key":"4815_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.922753","volume":"12","author":"Y Fu","year":"2022","unstructured":"Fu Y, Wu J, Wang D, Li T, Shi X, Li L, et al. Metagenomic profiling of ocular surface microbiome changes in Demodex blepharitis patients. Front Cell Infect Microbiol. 2022;12:922753.","journal-title":"Front Cell Infect Microbiol"},{"key":"4815_CR18","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2147\/OPTH.S215071","volume":"13","author":"A Nattis","year":"2019","unstructured":"Nattis A, Perry HD, Rosenberg ED, Donnenfeld ED. Influence of bacterial burden on meibomian gland dysfunction and ocular surface disease. Clin Ophthalmol. 2019;13:1225\u201334.","journal-title":"Clin Ophthalmol"},{"key":"4815_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.61.8.22","volume":"61","author":"F Zhao","year":"2020","unstructured":"Zhao F, Zhang D, Ge C, Zhang L, Reinach PS, Tian X, et al. Metagenomic Profiling of Ocular Surface Microbiome Changes in Meibomian Gland Dysfunction. Invest Ophthalmol Vis Sci. 2020;61:22.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04815-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04815-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04815-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:45:45Z","timestamp":1790167545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04815-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":19,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4815"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04815-4","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"15 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KA is a consultant for Abbvie, Alcon, Azura, Bausch and Lomb, Dompe, Harrow, Lenz Therapeutics, and Tarsus.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}